- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
The usage and dosage of Repotrectinib should be adjusted according to the patient type and adverse reactions. Special attention should be paid ...
Repotrectinib is a targeted therapy drug mainly used for ROS1 positive non-small cell lung cancer and NTRK gene fusion solid tumors. When using...
Repotrectinib, as a targeted therapy drug, must be strictly followed in terms of contraindications, dietary restrictions, and usage limitations...
Repotrectinib, as a targeted therapy drug, has a spectrum of side effects involving multiple systems and requires a graded management strategy ...
Sorafenib is a multi kinase inhibitor primarily used for the treatment of liver cancer, kidney cancer, and thyroid cancer. Its common side effe...
Sorafenib is a multi kinase inhibitor mainly used for the treatment of advanced liver and kidney cancer. Its use should focus on liver toxicity...
Sorafenib, as a multi kinase inhibitor, has clear contraindications, dietary restrictions, and special condition requirements for its use. The ...
The standard usage of Sorafenib is twice daily oral administration, taken on an empty stomach. For special populations, the dosage should be ad...
Dasatinib is a tyrosine kinase inhibitor primarily used for the treatment of hematological malignancies with specific gene mutations. Its use r...
Ocaliva, as a therapeutic drug for primary biliary cholangitis, mainly has side effects on the liver and gallbladder system, metabolic abnormal...
